adalimumab
Generic: adalimumab-aaty
Labeler: celltrion usa, inc.Drug Facts
Product Profile
Brand Name
adalimumab
Generic Name
adalimumab-aaty
Labeler
celltrion usa, inc.
Dosage Form
KIT
Manufacturer
Identifiers & Regulatory
Product NDC
72606-041
Product ID
72606-041_68fa51bf-22b5-4963-bc1c-9be00fb09b2a
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
BLA
Application Number
BLA761219
Listing Expiration
2026-12-31
Marketing Start
2023-11-30
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
72606041
Hyphenated Format
72606-041
Supplemental Identifiers
RxCUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
adalimumab (source: ndc)
Generic Name
adalimumab-aaty (source: ndc)
Application Number
BLA761219 (source: ndc)
Resolved Composition
Strengths
- 80 mg/0.8 ml
- 40 mg/0.4 ml
- 20 mg/0.2 ml
- 1 ml
Packaging
- 2 KIT in 1 CARTON (72606-041-01) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .2 mL in 1 SYRINGE * 1 mL in 1 PACKET
Packages (1)
Ingredients (0)
No ingredient records.
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"spl_id": "68fa51bf-22b5-4963-bc1c-9be00fb09b2a", "openfda": {"rxcui": ["797544", "2639651", "2639659", "2668483", "2668485", "2668487", "2668489"], "spl_set_id": ["c44365e9-d470-4e35-978d-8565a9e3471e"], "manufacturer_name": ["CELLTRION USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 KIT in 1 CARTON (72606-041-01) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .2 mL in 1 SYRINGE * 1 mL in 1 PACKET", "package_ndc": "72606-041-01", "marketing_start_date": "20231130"}], "brand_name": "Adalimumab", "product_id": "72606-041_68fa51bf-22b5-4963-bc1c-9be00fb09b2a", "dosage_form": "KIT", "product_ndc": "72606-041", "generic_name": "adalimumab-aaty", "labeler_name": "CELLTRION USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Adalimumab", "application_number": "BLA761219", "marketing_category": "BLA", "marketing_start_date": "20231130", "listing_expiration_date": "20261231"}